US Broker Ratings

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Potential Upside of Over 57% Ignites Investor Interest

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector, attracting attention with its promising pipeline and a substantial potential upside. With a market..

GH Research PLC (GHRS): Investor Outlook on a Biotech Stock with a 49% Potential Upside

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company headquartered in Dublin, Ireland, is capturing the attention of investors with its innovative approach to treating depression...

uniQure N.V. (QURE) Stock Analysis: A Biotech Powerhouse with a 56% Upside Potential

uniQure N.V. (QURE), a prominent player in the biotechnology sector, is catching the attention of investors with its robust portfolio of gene therapy candidates and a..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: A Look at Its 95.76% Potential Upside

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a cutting-edge biotechnology firm specializing in genome editing, offers intriguing possibilities for investors focused on the healthcare sector. With its headquarters..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A 50% Upside Potential Amidst Robust Revenue Growth

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), an innovative player in the healthcare sector, is attracting investor attention with its promising growth prospects. Specializing in developing therapies..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Navigating a Potential 7.54% Upside in the Biotech Arena

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of the biotechnology sector, focusing its efforts on developing innovative therapeutics for infectious diseases. Headquartered in Warminster,..

Auna SA (AUNA) Stock Analysis: Exploring a Compelling 35.91% Potential Upside

Auna SA (AUNA), a prominent player in the healthcare sector with operations spanning Mexico, Peru, and Colombia, presents an intriguing proposition for investors seeking promising growth..

Iovance Biotherapeutics (IOVA) Stock Analysis: Unpacking the 65.7% Revenue Growth Potential

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) stands at the forefront of the biotechnology sector, captivating investors with its promising advancements in cell therapy for cancer treatment. With..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating Healthcare Tech with a 15.5% Revenue Growth

Weave Communications, Inc. (NYSE: WEAV) is making waves in the healthcare technology sector with its innovative AI-driven solutions for patient communication and engagement. Headquartered in Lehi,..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring the 90.27% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), operating within the dynamic healthcare sector, is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic products to combat serious infectious..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 118% Potential Upside Beckons Investors

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, is garnering significant attention from investors, driven by its potential upside of 118.31%. With..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a Potential 281% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology firm based in Waltham, Massachusetts, is attracting significant attention from investors seeking opportunities in the healthcare sector. Specializing in the..

Rocket Pharmaceuticals, Inc. (RCKT)

⚠️ No article content returned.

..

Claritev Corporation (CTEV) Stock Analysis: Unpacking a 44.45% Upside Potential in Healthcare Innovation

Claritev Corporation (CTEV), a notable player in the healthcare sector, is making waves with its comprehensive suite of data analytics and technology-enabled solutions. Headquartered in McLean,..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Navigating the Biotech Seas with Strategic Collaborations

For investors eyeing the dynamic healthcare sector, Theravance Biopharma, Inc. (NASDAQ: TBPH) presents a fascinating proposition within the biotechnology industry. With a market capitalization of approximately..

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 51.72% Potential Upside in Biotechnology

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands as a compelling player in the biotechnology sector, capturing investor interest with a notable potential upside of 51.72% according to..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A 19.63% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL) is capturing the attention of investors with its promising growth potential in the healthcare sector. Specializing in molecular diagnostics, the company..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a Potential 68% Upside

Cogent Biosciences, Inc. (NASDAQ: COGT), a clinical-stage biotechnology firm, is becoming an intriguing prospect for investors seeking exposure in the healthcare sector, particularly within biotechnology. With..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Potential 47.69% Upside in the Oncology Device Market

Delcath Systems, Inc. (DCTH), a healthcare player specializing in medical devices, has been gaining investor attention due to its innovative approach in the treatment of liver..

Zenas BioPharma, Inc. (ZBIO): Analyst Ratings Suggest a 47% Upside in Biotech Investment

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline of immunology-based therapies. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds